Biodesix Affirms FY2026 Sales Guidance of $108.000M-$114.000M vs $110.996M Est

Biodesix (NASDAQ:BDSX) affirms FY2026 sales outlook from $108.000 million-$114.000 million to $108.000 million-$114.000 million vs $110.996 million estimate.